ResearchIn-Press PreviewImmunologyInfectious disease Open Access | 10.1172/jci.insight.186346
1Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, United States of America
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, United States of America
Find articles by Popescu, N. in: JCI | PubMed | Google Scholar
1Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, United States of America
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, United States of America
Find articles by Kluza, J. in: JCI | PubMed | Google Scholar
1Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, United States of America
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, United States of America
Find articles by Reidy, M. in: JCI | PubMed | Google Scholar
1Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, United States of America
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, United States of America
Find articles by Duggan, E. in: JCI | PubMed | Google Scholar
1Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, United States of America
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, United States of America
Find articles by Lambris, J. in: JCI | PubMed | Google Scholar |
1Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, United States of America
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, United States of America
Find articles by Thompson, L. in: JCI | PubMed | Google Scholar
1Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, United States of America
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, United States of America
Find articles by Coggeshall, K. in: JCI | PubMed | Google Scholar
Published December 10, 2024 - More info
Peptidoglycans (PGNs) are structural polymers of the bacterial cell wall and a common microbial molecular pattern encountered by our immune system daily. Low levels of PGNs are constitutively present in the systemic circulation in humans and elevate during inflammatory pathologies. Since all known PGN sensors are intracellular, PGN internalization is a prerequisite for the initiation of cellular immune responses. Here we report the mechanisms controlling the recognition and uptake of polymeric PGNs by circulating human mononuclear phagocytes. We found that complement C3 and C4 opsonins govern PGN recognition and internalization, but no single opsonin is indispensable due to multiple uptake redundancies. We observed a bimodal internalization of polymeric PGNs with distinct requirements for complement C4. At low PGN concentrations, C3 mediated PGN recognition by surface receptors while the efficient internalization of PGN polymers critically required C4. Supraphysiologic PGN concentrations triggered a secondary uptake modality that was insensitive to C4 and mediated instead by C3 engagement of complement receptors 1 and 3. To our knowledge this is the first description of non-overlapping C3 and C4 opsonophagocytoses working in parallel. Controlling these uptake mechanisms has the potential to modulate PGN clearance and/or the dysregulated immune responses during bacterial infections.